CLINICAL_TRIALS
trial_result
· 2023-08-16
Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis [Phase 2]
Summary
Phase 2 trial evaluating CCX168 for ANCA-associated vasculitis has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: ANCA-associated Vasculitis | Phase 2 | Status: COMPLETED | Results posted: 2023-08-16